Back
Cogent Biosciences Vs. NovaBay Pharmaceuticals Industry Stock Comparison
Sell
29
COGT
Cogent Biosciences
Last Price:
6.44
Seasonality Move:
156.05%
Sell
5
NBY
NovaBay Pharmaceuticals
Last Price:
0.08
Seasonality Move:
-9.04%
Sell
29
Cogent Biosciences (COGT)
is a Sell
Is Cogent Biosciences a Buy, Sell or Hold?
- The current Cogent Biosciences [COGT] share price is $6.51. The Score for COGT is 29, which is 42% below its historic median score of 50, and infers higher risk than normal.
- COGT is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
5
NovaBay Pharmaceuticals (NBY)
is a Sell
Is NovaBay Pharmaceuticals a Buy, Sell or Hold?
- The current NovaBay Pharmaceuticals [NBY] share price is $0.08. The Score for NBY is 5, which is 90% below its historic median score of 50, and infers higher risk than normal.
- NBY is currently trading in the 0-10% percentile range relative to its historical Stock Score levels.
- This Score is currently showing an extreme reading that indicates risk could be especially high.
COGT Stock Price Chart
What is Cogent Biosciences's stock price today?
-
The Cogent Biosciences share price today is $6.51
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and COGT is experiencing slight selling pressure.
NBY Stock Price Chart
What is NovaBay Pharmaceuticals's stock price today?
-
The NovaBay Pharmaceuticals share price today is $0.08
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and NBY is experiencing selling pressure, which indicates risk of future bearish movement.
COGT Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.03 | Sell |
| Relative Strength Index (14 RSI): | 47.37 | Sell |
| Chaikin Money Flow: | -276703 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (6.31 - 6.89) | Sell |
| Bollinger Bands (100): | (5.04 - 7.56) | Buy |
NBY Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.02 | Sell |
| Relative Strength Index (14 RSI): | 24.55 | Sell |
| Chaikin Money Flow: | -1643998 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (0.1 - 0.14) | Sell |
| Bollinger Bands (100): | (0.11 - 0.25) | Sell |
COGT Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 6.66 | Sell |
| 20-day SMA: | 6.6 | Sell |
| 50-day SMA: | 6.84 | Sell |
| 200-day SMA: | 8.52 | Sell |
| 8-day EMA: | 6.61 | Sell |
| 20-day EMA: | 6.65 | Sell |
| 50-day EMA: | 6.63 | Sell |
| 200-day EMA: | 8.01 | Sell |
NBY Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 0.09 | Sell |
| 20-day SMA: | 0.11 | Sell |
| 50-day SMA: | 0.13 | Sell |
| 200-day SMA: | 0.36 | Sell |
| 8-day EMA: | 0.09 | Sell |
| 20-day EMA: | 0.11 | Sell |
| 50-day EMA: | 0.14 | Sell |
| 200-day EMA: | 0.61 | Sell |
Cogent Biosciences Earnings Growth & COGT Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.05 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.45 per share, and a decrease next year of $0.12 per share.
NovaBay Pharmaceuticals Earnings Growth & NBY Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.32 per share, an increase next quarter of $0.05 per share, an increase this year of $1.90 per share, and an increase next year of $0.48 per share.
Cogent Biosciences Technical Analysis
| Apr 2 | Apr 3 | Apr 4 | Apr 5 | Apr 8 | Apr 9 | Apr 10 | Apr 11 | Apr 12 | Apr 15 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr | ||||||||||
| 02 | 03 | 04 | 05 | 08 | 09 | 10 | 11 | 12 | 15 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
NovaBay Pharmaceuticals Technical Analysis
| Apr 2 | Apr 3 | Apr 4 | Apr 5 | Apr 8 | Apr 9 | Apr 10 | Apr 11 | Apr 12 | Apr 15 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr | ||||||||||
| 02 | 03 | 04 | 05 | 08 | 09 | 10 | 11 | 12 | 15 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||